← FDA Drug Approvals (Drugs@FDA)

BORTEZOMIB

NDA · New Drug Application · Sponsor: ACCORD HLTHCARE · Approved 2022-07-26

Drug application

FDA Application #

NDA215441

Application type

New Drug Application

Brand name

BORTEZOMIB

Generic name

Bortezomib

Active ingredients

BORTEZOMIB

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

ACCORD HLTHCARE

First approval

2022-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown